Claims Firms Barred From Misleading Plaintiffs In Pharma MDL
By James Boyle · November 20, 2025, 4:14 PM EST
On the same day that a Philadelphia federal judge approved $58 million in settlements as part of an ongoing generic-drug price-fixing multidistrict litigation, she also ordered several claims recovery firms to...
To view the full article, register now.